Anna‐Karin Wihlborg
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Atrial Fibrillation Management and Outcomes, Nitric Oxide and Endothelin Effects, Multiple Myeloma Research and Treatments, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → ADP Receptor P2Y 12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels(2004)183 cited
- → Plasticity of TRPC expression in arterial smooth muscle: correlation with store-operated Ca2+ entry(2004)159 cited
- → Identification of sequence variants influencing immunoglobulin levels(2017)119 cited
- → Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma(2018)113 cited
- → Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factor(2003)89 cited
- → Methanocarba Modification of Uracil and Adenine Nucleotides: High Potency of Northern Ring Conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but Not P2Y6 Receptors(2001)84 cited
- → Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12(2006)16 cited
- → Methanocarba Modification of Uracil and Adenine Nucleotides: High Potency of Northern Ring Conformation at P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 11 but Not P2Y 6 Receptors(2020)6 cited
- → Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden(2019)3 cited
- → 2,2′‐Nitrophenylisatogen potentiates P2X1 receptor mediated vascular contraction and blood pressure elevation(2003)3 cited